Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Comella

Showing results (481-490 of 685) with videos related to

Pageof 69
Sort By:
Scientific Reports|October 22, 2016
FAIM-L regulation of XIAP degradation modulates Synaptic Long-Term Depression and Axon DegenerationRamón Martínez-Mármol, Bruna Barneda-Zahonero, David Soto, et al.
Cancer Journal (Sudbury, Mass.)|August 2, 2005
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlatesGiampietro Gasparini, Sabrina Meo, Giuseppe Comella, et al.
Tumori|November 10, 2005
Cost of insurance policies for investigator-initiated cancer clinical trials in ItalyFrancesco Perrone, Maurizio Marangolo, Francesco Di Costanzo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Fatigue in Parkinson's disease: a reviewJoseph H Friedman, Richard G Brown, Cynthia Comella, et al.
Open Heart|October 2, 2020
Non-hyperaemic pressure ratios to guide percutaneous coronary interventionMichael Michail, Udit Thakur, Ojas Mehta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 4, 2024
Targeting liver and adipose tissue in obese mice: Effects of a N-acylethanolamine mixture on insulin resistance and adipocyte reprogrammingS Melini, A Lama, F Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Insurance for independent cancer trialsF Perrone, M Marangolo, F Di Costanzo, et al.
Journal of Neuroimmunology|May 6, 2014
Activation-induced cell death in T lymphocytes from multiple sclerosis patientsMontserrat Moreno, Laura Negrotto, Jordi Río, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lymphomasSalvatore Tafuto, Orlando Catalano, Gianvincenzo Barba, et al.
Pageof 69

Showing results (481-490 of 685) with videos related to

Sort By:
Pageof 69
Scientific Reports|October 22, 2016
FAIM-L regulation of XIAP degradation modulates Synaptic Long-Term Depression and Axon DegenerationRamón Martínez-Mármol, Bruna Barneda-Zahonero, David Soto, et al.
Cancer Journal (Sudbury, Mass.)|August 2, 2005
The combination of the selective cyclooxygenase-2 inhibitor celecoxib with weekly paclitaxel is a safe and active second-line therapy for non-small cell lung cancer: a phase II study with biological correlatesGiampietro Gasparini, Sabrina Meo, Giuseppe Comella, et al.
Tumori|November 10, 2005
Cost of insurance policies for investigator-initiated cancer clinical trials in ItalyFrancesco Perrone, Maurizio Marangolo, Francesco Di Costanzo, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 30, 2006
Fatigue in Parkinson's disease: a reviewJoseph H Friedman, Richard G Brown, Cynthia Comella, et al.
Open Heart|October 2, 2020
Non-hyperaemic pressure ratios to guide percutaneous coronary interventionMichael Michail, Udit Thakur, Ojas Mehta, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 4, 2024
Targeting liver and adipose tissue in obese mice: Effects of a N-acylethanolamine mixture on insulin resistance and adipocyte reprogrammingS Melini, A Lama, F Comella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Insurance for independent cancer trialsF Perrone, M Marangolo, F Di Costanzo, et al.
Journal of Neuroimmunology|May 6, 2014
Activation-induced cell death in T lymphocytes from multiple sclerosis patientsMontserrat Moreno, Laura Negrotto, Jordi Río, et al.
Journal of Clinical Psychopharmacology|November 6, 2019
A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive DyskinesiaStephen R Marder, Carlos Singer, Jean-Pierre Lindenmayer, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 25, 2006
Real-time contrast-enhanced specific ultrasound in staging and follow-up of splenic lymphomasSalvatore Tafuto, Orlando Catalano, Gianvincenzo Barba, et al.
Pageof 69